Evidence map›Paper›PMID 36110932›Full record

ArticleFrontiers in oncology2022

Differentiation of different stages of brain tumor infiltration using optical coherence tomography: Comparison of two systems and histology.

Paul Strenge, Birgit Lange, Wolfgang Draxinger, Christin Grill, Veit Danicke, Dirk Theisen-Kunde, Christian Hagel, Sonja Spahr-Hess, Matteo M Bonsanto, Heinz Handels and 2 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Paul StrengeMedical Laser Center Luebeck, Luebeck, Germany.
Birgit LangeMedical Laser Center Luebeck, Luebeck, Germany.
Wolfgang DraxingerInstitute of Biomedical Optics, University of Luebeck, Luebeck, Germany.
Christin GrillInstitute of Biomedical Optics, University of Luebeck, Luebeck, Germany.
Veit DanickeMedical Laser Center Luebeck, Luebeck, Germany.
Dirk Theisen-KundeMedical Laser Center Luebeck, Luebeck, Germany.
Christian HagelInstitute for Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Sonja Spahr-HessDepartment of Neurosurgery, University Medical Center Schleswig-Holstein, Luebeck, Germany.
Matteo M BonsantoDepartment of Neurosurgery, University Medical Center Schleswig-Holstein, Luebeck, Germany.
Heinz HandelsInstitute of Medical Informatics, University of Luebeck, Luebeck, Germany.
Robert HuberInstitute of Biomedical Optics, University of Luebeck, Luebeck, Germany.
Ralf BrinkmannMedical Laser Center Luebeck, Luebeck, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The discrimination of tumor-infiltrated tissue from non-tumorous brain tissue during neurosurgical tumor excision is a major challenge in neurosurgery. It is critical to achieve full tumor removal since it directly correlates with the survival rate of the patient. Optical coherence tomography (OCT) might be an additional imaging method in the field of neurosurgery that enables the classification of different levels of tumor infiltration and non-tumorous tissue. This work investigated two OCT systems with different imaging wavelengths (930 nm/1310 nm) and different resolutions (axial (air): 4.9 μm/16 μm, lateral: 5.2 μm/22 μm) in their ability to identify different levels of tumor infiltration based on freshly excised

Indexed as

attenuation (absorption) coefficientbrainglioblastoma multiformeneural networkOCToptical coherence tomographytumor

Identifiers

PMID36110932
PMCPMC9468861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.